- $2.34bn
- $2.34bn
- $12.80m
Brief: Applied Digital To Spin Out Cloud Business, Proposes Business Combination With EKSO To Launch Chronoscale
Brief: Ekso Bionics Inks Agreement To Become The Exclusive U.S. Distributor Of Meditouch’S Groundbreaking Balancetutor Rehabilitation System
Brief: Ekso Bionics Announces $3.7 Million Registered Direct Offering Of Common Stock Priced At-The-Market Under Nasdaq Rules
Brief: Ekso Bionics Reports Third Quarter 2025 Financial Results
Ekso Bionics' Q3 revenue up on high margin sales
Brief: Ekso Bionics Q3 Net Income USD -1.421 Million
Brief: Ekso Bionics Enters Secured Promissory Note And Security Agreement - SEC Filing
Ekso Bionics Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Ekso Bionics Q2 revenue misses estimates, net loss widens
Ekso Bionics Holdings Inc expected to post a loss of $1.35 a share - Earnings Preview
Brief: Ekso Bionics Announces New Effective Date Of Reverse Stock Split
Brief: Ekso Bionics Announces Reverse Stock Split
Ekso Bionics Holdings Inc reports results for the quarter ended March 31 - Earnings Summary
Ekso Bionics Holdings Inc expected to post a loss of 11 cents a share - Earnings Preview
Ekso Bionics Holdings Inc expected to post a loss of 11 cents a share - Earnings Preview
Ekso Bionics Holdings Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results
Ekso Bionics Holdings Inc expected to post a loss of 8 cents a share - Earnings Preview
Ekso Bionics Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary